Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The discovery and design of novel HIV-1 capsid modulators and future perspectives
Dang Ding, Shujing Xu, Xujie Zhang, et al.
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 1, pp. 5-12
Closed Access | Times Cited: 11

Showing 11 citing articles:

Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023
Sheng Han, Yiming Lu
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115586-115586
Closed Access | Times Cited: 15
Medicinal chemistry strategies in the discovery and optimization of HBV core protein allosteric modulators (2018–2022 update)
Xiaoyu Shao, Shujing Xu, Xufeng Wan, et al.
Chinese Chemical Letters (2023) Vol. 34, Iss. 11, pp. 108349-108349
Closed Access | Times Cited: 10
Design and Synthesis of New GS-6207 Subtypes for Targeting HIV-1 Capsid Protein
Thamina Akther, William M. McFadden, Huanchun Zhang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3734-3734
Open Access | Times Cited: 3
A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect
Yi‐Ru Bai, Xin Yang, Ken Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116759-116759
Closed Access | Times Cited: 3
Antiviral Properties of HIV-1 Capsid Inhibitor GSK878
Chunfu Wang, Haichang Huang, Kirsten Mallon, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 5
Open Access | Times Cited: 6
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators
Shujing Xu, Lin Sun, Michael J. Barnett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16303-16329
Open Access | Times Cited: 5
Viral Protein Dimerization Quality Control: A Design Strategy for a Potential Viral Inhibitor
Shaoqing Du, Xinyong Liu, Xueping Hu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
“Pseudosubstrate Envelope”/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency
Shujing Xu, Shuo Wang, Yang Zhou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19057-19076
Closed Access
Recent progress in therapeutic applications of fluorinated five-membered heterocycles and their benzo-fused systems
Ashraf A. Abbas, Thoraya A. Farghaly, Kamal M. Dawood
RSC Advances (2024) Vol. 14, Iss. 46, pp. 33864-33905
Open Access
Lenacapavir: a first-in-class HIV-1 capsid inhibitor for the treatment of multidrug-resistant HIV infections
Dang Ding, Dazhou Shi, Shujing Xu, et al.
Elsevier eBooks (2024), pp. 341-349
Closed Access
Bibliometric analysis and visualization of research trends on HIV-1 capsid inhibitors (2000–2022)
Lin Sun, Tongchao Zhang, Shujing Xu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access
Page 1

Scroll to top